Related references
Note: Only part of the references are listed.Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge
Tanja Opriessnig et al.
VACCINE (2020)
T cell epitope content comparison (EpiCC) analysis demonstrates a bivalent PCV2 vaccine has greater T cell epitope overlap with field strains than monovalent PCV2 vaccines
Meggan Bandrick et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2020)
Detection and genotyping of Porcine circovirus 2 (PCV-2) and detection of Porcine circovirus 3 (PCV-3) in sera from fattening pigs of different European countries
Viviane Saporiti et al.
TRANSBOUNDARY AND EMERGING DISEASES (2020)
Frequency of Detection and Phylogenetic Analysis of Porcine circovirus 3 (PCV-3) in Healthy Primiparous and Multiparous Sows and Their Mummified Fetuses and Stillborn
Viviane Saporiti et al.
PATHOGENS (2020)
Genetic diversity and different cross-neutralization capability of porcine circovirus type 2 isolates recently circulating in South Korea
Seok-Jin Kang et al.
BMC VETERINARY RESEARCH (2020)
Phylogenetic and genetic variation analyses of porcine circovirus type 2 isolated from China
S. Yang et al.
TRANSBOUNDARY AND EMERGING DISEASES (2018)
Porcine circovirus 2 (PCV-2) genotype update and proposal of a new genotyping methodology
Giovanni Franzo et al.
PLOS ONE (2018)
PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the US during 2014-2016
Chao-Ting Xiao et al.
VETERINARY MICROBIOLOGY (2016)
Global molecular genetic analysis of porcine circovirus type 2 (PCV2) sequences confirms the presence of four main PCV2 genotypes and reveals a rapid increase of PCV2d
Chao-Ting Xiao et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines
Cinzia Zanotti et al.
VIRAL IMMUNOLOGY (2015)
Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ
Anthony L. Desbien et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Best practice and future challenges for vaccination against porcine circovirus type 2
Joaquim Segales
EXPERT REVIEW OF VACCINES (2015)
Serum haptoglobin dynamics in pigs vaccinated or not vaccinated against porcine circovirus type 2
Lorenzo Fraile et al.
PORCINE HEALTH MANAGEMENT (2015)
Comparison of Four Commercial One-Dose Porcine Circovirus Type 2 (PCV2) Vaccines Administered to Pigs Challenged with PCV2 and Porcine Reproductive and Respiratory Syndrome Virus at 17 Weeks Postvaccination To Control Porcine Respiratory Disease Complex under Korean Field Conditions
Changhoon Park et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Comparative analyses of humoral and cell-mediated immune responses upon vaccination with different commercially available single-dose porcine circovirus type 2 vaccines
Hwi Won Seo et al.
RESEARCH IN VETERINARY SCIENCE (2014)
Comparison of the immunoperoxidase monolayer assay and three commercial ELISAs for detection of antibodies against porcine circovirus type 2
E. Pileri et al.
VETERINARY JOURNAL (2014)
Memory T cell proliferative responses and IFN-γ. productivity sustain long-lasting efficacy of a Cap-based PCV2 vaccine upon PCV2 natural infection and associated disease
Luca Ferrari et al.
VETERINARY RESEARCH (2014)
Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes
Jianbo Liu et al.
VETERINARY MICROBIOLOGY (2013)
Mechanisms of action of adjuvants
Sunita Awate et al.
FRONTIERS IN IMMUNOLOGY (2013)
Single amino acid mutations in the capsid switch the neutralization phenotype of porcine circovirus 2
Dipongkor Saha et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Protective effect of the maternally derived porcine circovirus type 2 (PCV2)-specific cellular immune response in piglets by dam vaccination against PCV2 challenge
Yeonsu Oh et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Commercial porcine circovirus type 2 vaccines: Efficacy and clinical application
Chanhee Chae
VETERINARY JOURNAL (2012)
Antigenic subtyping and epitopes' competition analysis of porcine circovirus type 2 using monoclonal antibodies
Dipongkor Saha et al.
VETERINARY MICROBIOLOGY (2012)
Porcine circovirus type 2 (PCV2) infections: Clinical signs, pathology and laboratory diagnosis
Joaquim Segales
VIRUS RESEARCH (2012)
Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2
D. Kim et al.
VACCINE (2011)
Optimal combinations of acute phase proteins for detecting infectious disease in pigs
Peter M. H. Heegaard et al.
VETERINARY RESEARCH (2011)
Insights into the Evolutionary History of an Emerging Livestock Pathogen: Porcine Circovirus 2
Cadhla Firth et al.
JOURNAL OF VIROLOGY (2009)
One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model
M. Fort et al.
VACCINE (2009)
Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV-PCV2-SIV clinical infection model 2-3-months post vaccination
T. Opriessnig et al.
VACCINE (2009)
Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets
Maria Fort et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2009)
Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins
M. Fort et al.
VACCINE (2008)
Translating innate immunity into immunological memory: Implications for vaccine development
B Pulendran et al.
CELL (2006)
A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs
M Fenaux et al.
JOURNAL OF VIROLOGY (2004)
Share Paper
